Yakup Ergün· @dr_yakupergun · X·· 2 天前评分70
正文 · 机器翻译
#ESMO26 | DESTINY-Breast11
MRI 疗效不能可靠地预测 pCR。这是根据疗效指导新辅助治疗个体化的一个重要限制。
1220 浏览 · 14 赞 · 5 转发 · 0 回复
会议摘要
543RO按 Rapid oral: Breast cancer, early stage 对上
DESTINY-Breast11: MRI-assessed objective responses during neoadjuvant treatment (NAT) with trastuzumab deruxtecan (T-DXd) followed by paclitaxel + trastuzumab + pertuzumab (THP) vs dose-dense doxorubicin + cyclophosphamide followed by THP (
https://esmocongress.esmo.org来源：Yakup Ergün · x.com